Evidence map›Paper›PMID 42757296›Full record

ArticleIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine2026

Sulbactam-Durlobactam for Carbapenem-resistant

Vinay Gandhi Mukkelli, Rajat Gupta

Abstract read
In one paragraph

Article in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vinay Gandhi MukkelliDepartment of Anaesthesiology Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India.ORCID https://orcid.org/0009-0006-6738-3167
Rajat GuptaDepartment of Emergency and Critical Care, Sri Balaji Action Medical Institute, New Delhi, India.ORCID https://orcid.org/0009-0005-4239-5842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mukkelli VG, Gupta R. Sulbactam-Durlobactam for Carbapenem-resistant Acinetobacter baumannii in India: Does Local Molecular Epidemiology Support Current Guideline Recommendations? Indian J Crit Care Med 2026;30(8):698-699.

Indexed as

Carbapenem-resistant Acinetobacter baumanniiClinical practice guidelinesGram negative bacteriaNew Delhi metallo-β-lactamase gene

Identifiers

PMID42757296
PMCPMC13585087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.